The FDA's new authorization of an at-home syphilis test is a significant breakthrough in tackling the national surge of sexually transmitted infections (STIs), particularly syphilis.
Cases of syphilis have exploded in the U.S., rising nearly 80% from 2018 to 2022, reaching over 207,000, the highest in 70 years, affecting women and pregnancies.
The test, which gives results in 15 minutes using finger prick blood samples, allows individuals to test privately at home, circumventing stigma associated with sexual health discussions.
Jeffrey Klausner emphasized that the new syphilis assay not only provides rapid results but also addresses the critical need for privacy in screening for STIs at home.
[
Collection
]
[
|
...
]